BSE Live
Mar 09, 16:01Prev. Close
152.05
Open Price
147.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 09, 15:59Prev. Close
151.87
Open Price
149.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
151.40 (300)
| Key Financial Ratios of Piramal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.69 | 0.14 | -1.57 | 3.19 | 18.56 | |
| Diluted EPS (Rs.) | 0.68 | 0.14 | -1.57 | 3.19 | 18.56 | |
| Cash EPS (Rs.) | 6.30 | 5.28 | 3.65 | 7.62 | 13.40 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 61.35 | 59.80 | 56.76 | 56.47 | 56.35 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 61.35 | 59.80 | 56.76 | 56.47 | 56.35 | |
| Revenue from Operations/Share (Rs.) | 69.10 | 61.76 | 59.34 | 55.31 | 63.49 | |
| PBDIT/Share (Rs.) | 11.93 | 10.37 | 7.15 | 10.33 | 16.01 | |
| PBIT/Share (Rs.) | 5.76 | 4.77 | 1.48 | 5.39 | 10.53 | |
| PBT/Share (Rs.) | 2.58 | 0.91 | -1.46 | 3.59 | 9.07 | |
| Net Profit/Share (Rs.) | 0.14 | -0.31 | -2.02 | 2.67 | 7.92 | |
| NP After MI And SOA / Share (Rs.) | 0.69 | 0.13 | -1.56 | 3.17 | 8.40 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 17.26 | 16.78 | 12.05 | 18.68 | 25.21 | |
| PBIT Margin (%) | 8.34 | 7.72 | 2.49 | 9.74 | 16.58 | |
| PBT Margin (%) | 3.73 | 1.46 | -2.46 | 6.49 | 14.28 | |
| Net Profit Margin (%) | 0.19 | -0.50 | -3.40 | 4.83 | 12.47 | |
| NP After MI And SOA Margin (%) | 0.99 | 0.21 | -2.63 | 5.73 | 13.22 | |
| Return on Networth/Equity (%) | 1.12 | 0.22 | -2.75 | 5.61 | 14.89 | |
| Return on Capital Employed (%) | 6.40 | 5.76 | 1.65 | 6.54 | 12.45 | |
| Return on Assets (%) | 0.58 | 0.11 | -1.28 | 2.93 | 7.66 | |
| Total Debt/Equity (X) | 0.58 | 0.58 | 0.81 | 0.60 | 0.48 | |
| Asset Turnover Ratio (%) | 0.59 | 0.55 | 0.33 | 0.34 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.54 | 1.25 | 1.26 | 1.34 | 1.47 | |
| Quick Ratio (X) | 0.93 | 0.75 | 0.82 | 0.88 | 0.97 | |
| Inventory Turnover Ratio (X) | 4.08 | 1.02 | 1.06 | 1.17 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 15.87 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 1.59 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 84.13 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 98.41 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 3.75 | 3.06 | 2.48 | 6.18 | 9.74 | |
| Interest Coverage Ratios (Post Tax) (%) | 3.75 | 3.06 | 2.48 | 6.18 | 9.74 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 33,950.47 | 21,129.13 | 13,363.10 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 3.71 | 2.59 | 1.89 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 21.49 | 15.40 | 15.66 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 3.25 | 2.09 | 1.15 | 0.00 | 0.00 | |
| Retention Ratios (%) | 84.12 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 3.66 | 2.16 | 1.21 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 3.25 | 2.09 | 1.15 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 |
24.02.2026
15.02.2026
02.02.2026
30.01.2026
Piramal Pharma Consolidated December 2025 Net Sales at Rs 2,139.87 crore, down 2.92% Y-o-Y
30.01.2026
Piramal Pharma Consolidated December 2025 Net Sales at Rs 2,139.87 crore, down 2.92% Y-o-Y
30.01.2026
Piramal Pharma Standalone December 2025 Net Sales at Rs 1,195.81 crore, down 4.21% Y-o-Y
12.11.2025
Piramal Pharma Standalone September 2025 Net Sales at Rs 1,127.26 crore, down 12.23% Y-o-Y
06.11.2025
Piramal Pharma Consolidated September 2025 Net Sales at Rs 2,043.72 crore, down 8.83% Y-o-Y